Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT04056260

ICG-NIR Guided Lymph Node Dissection in Gastric Cancer

Conditions: Stomach Neoplasm

Sex: All
Ages: 20 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 219
Sponsor: Ho Seok Seo

Location: Seoul St. Mary's Hospital, The Catholic University of Korea Seoul

Summary

As the survival rate of patients with gastric cancer has increased, there has been a growing interest in interventions that improve postoperative quality of life. Therefore minimally invasive surgery or endoscopic resection has been performed much more frequently. However, adequate lymph node dissection is important as well. The aim of the study is to identify the feasibility of indocyanine green - near infra-red (ICG-NIR) guided sentinel lymph node dissection for the treatment of gastric cancer.

Eligibility Criteria

Inclusion Criteria: * dignosed gastric adenocarcinoma * tumor: size 4cm or smaller * depth of invasion: mucosa, submucosa, proper muscle * candidates of laparoscopic radical gastrectomy * informed consent Exclusion Criteria: * metachronous malignancy * number of tumors: 2 or more * remnant gastric cancer * indication for endoscopic resection * history of chemotherapy or radiation therapy * pregnancy * allergy to ICG * metastatic gastric cancer

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04056260). StuddyBuddy aggregates publicly available trial information.